Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Cardiology Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

A Look at the Glaucoma Armamentarium

By: Jason Bacharach, MD; and Albert Khouri, MD

Webinar Credits: 1

Expiration Date: Tuesday, January 31, 2023
Release Date: February 8, 2020

Learning Objectives

At the completion of this educational activity, you will be better able to:

  • Identify the mechanisms of action as well as the efficacy and safety profiles of novel trabecular outflow medications.
  • Demonstrate proficiency in selecting appropriate therapies to achieve individualized patient-specific treatment goals.
  • Advocate for patients who would benefit from new drugs before they are incorporated into payors’ formularies.

Accreditation and Designation Statement

Accreditation Statement
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve Medical Education LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This course is COPE approved for 1.0 hour of CE credit for optometrists.

Sponsored by: State University of New York College of Optometry

Evolve is an approved COPE Administrator.

COPE Course ID: 66659-GL

COPE Event ID: 118883

Faculty and Disclosures

Jason Bacharach, MD
Director, Glaucoma Division
California Pacific Medical Center
San Francisco, California
Medical Director & Founding Partner
North Bay Eye Associates Inc.
Sonoma County, California

Dr. Bacharach and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Allergan, Bausch + Lomb, Ellex, EyePoint Pharmaceuticals, Glaukos, New World Medical, Optovue, and Osmotica. Grant/Research Support: Aerie Pharmaceuticals, Allergan, Bausch + Lomb, Biorasi, Equinox, Eyepoint Pharmaceuticals, Glaukos, Nicox, Optovue, Santen, and Sun. Speaker’s Bureau: Alcon, Allergan, Glaukos, and New World Medical. Stock/Shareholder: Aerie Pharmaceuticals, Injectsense, and Osmotica.

 

Albert S. Khouri, MD
Associate Professor of Ophthalmology
Director, Glaucoma Service
Director, Ophthalmology Residency
Rutgers New Jersey Medical School
Newark, New Jersey

Dr. Khouri and/or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Glaukos, and Eyenovia. Speaker’s Bureau: Aerie Pharmaceuticals, Allergan, and Bausch + Lomb. Grant Support: Allergan, Optovue, and NJ Health Foundation.

 

Editorial Support Disclosures

  • Erin K. Fletcher, MIT, director of compliance and education, Evolve, has no financial relationships with commercial interests.
  • Susan Gallagher-Pecha, director of client services and project management, Evolve, has no financial relationships with commercial interests.
  • Cassandra Richards, director of education development, Evolve, has no financial relationships with commercial interests.
  • Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.

 

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC,  Aerie Pharmaceuticals, or Bausch + Lomb.

Video Resources

BackNext
You Passed!

Congratulations!

You have already passed this test with a score of:

80%

Back